| USD millions | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Research & development | 25.2 | 33.0 | 37.9 | 43.7 | 41.8 | 37.6 | −10.1% | |
| Selling, general & administrative | 5.9 | 9.0 | 13.1 | 12.2 | 11.0 | 13.8 | +25.2% | |
| Selling & marketing | 0.2 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | — | |
| Operating expenses | 31.1 | 42.0 | 51.0 | 55.8 | 52.9 | 51.4 | −2.8% | |
| Operating income | (31.1) | (42.0) | (51.0) | (55.8) | (52.9) | (51.4) | +2.8% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 1.0 | 0.0 | 0.0 | — | |
| Interest income | 0.2 | 0.0 | 0.9 | 6.5 | 7.3 | 4.7 | −36.1% | |
| Other income / expense | 0.5 | (0.2) | 0.0 | 8.3 | 7.6 | 4.4 | −42.2% | |
| Pre-tax income | (30.6) | (42.2) | (50.9) | (47.5) | (45.3) | (47.0) | −3.8% | |
| Income tax | (4.4) | (4.3) | (3.0) | 0.0 | (2.3) | (0.6) | +71.7% | |
| Net income | (26.3) | (37.9) | (48.0) | (47.5) | (43.0) | (46.4) | −7.8% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.45) | (0.54) | (0.62) | (0.60) | (0.52) | (0.54) | −3.8% | |
| EPS, diluted (per share) | (0.45) | (0.54) | (0.62) | (0.60) | (0.52) | (0.54) | −3.8% | |
| EBITDA | (30.6) | (42.2) | (50.9) | (49.3) | (45.3) | (47.0) | −3.8% | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 50.6 | 0.0 | −100.0% | |
| Weighted average shares (shares) | 58,194,894 | 69,802,960 | 76,909,993 | 79,787,000 | 83,468,049 | 85,289,447 | +2.2% | |
| Weighted average diluted shares (shares) | 58,194,894 | 69,802,960 | 76,909,993 | 79,787,000 | 83,468,049 | 85,289,447 | +2.2% |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
